Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA binding motif protein 27 (RBM27) is a nuclear RNA-binding protein containing RNA recognition motifs, involved in RNA metabolism and post-transcriptional regulation of gene expression[3][7]. It is predicted to participate in the turnover of polyadenylated nuclear RNA, possibly through association with the nuclear RNA exosome complex as part of the PAXT connection[1][7]. Functional studies and ortholog analysis indicate it can negatively regulate factors associated with mitoribosome assembly, with roles in protecting mitochondria and preventing axon degeneration during neurodevelopment[1]. RBM27 is broadly expressed in multiple tissues, with nuclear localization and possible involvement in neurodevelopmental disorders such as autism based on genetic association studies[1][3][7]. No therapeutic drugs target RBM27, and it is not considered a classical therapeutic target such as a receptor or enzyme.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA binding motif protein 27 (RBM27).